Joint venture to benefit presbyopia patients

Article

Technolas Perfect Vision is the new company name for the joint venture between Bausch & Lomb and 20/10 Perfect Vision AG that will focus on laser vision correction.

Technolas Perfect Vision is the new company name for the joint venture between Bausch & Lomb and 20/10 Perfect Vision AG that will focus on laser vision correction.

The business will initially concentrate on treatments for presbyopia and aims to provide clinicians with advanced excimer and femtosecond laser technology. One of its new procedures is INTRACOR, an intrastromal treatment, which carries the CE mark for treatment of presbyopic hypreopes.

Dr Kristian Hohla, Technolas's new CEO sees this as potentially huge: "These are breakthrough technologies, transforming the lifestyle of presbyopia sufferers and providing clinicians with a wonderful opportunity to attract a stream of new patients to their refractive practices."

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.